{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:32:29Z","timestamp":1792114349123,"version":"4.4.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K08 AG34628"],"award-info":[{"award-number":["K08 AG34628"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RC1 AG035878"],"award-info":[{"award-number":["RC1 AG035878"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"NIA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005366","name":"AFAR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000909","name":"John A. Hartford Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000909","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004426","name":"Atlantic Philanthropies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004426","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009784","name":"Starr Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009784","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.nbd.2015.09.002","type":"journal-article","created":{"date-parts":[[2015,9,13]],"date-time":"2015-09-13T01:54:34Z","timestamp":1442109274000},"page":"552-560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"C","title":["Dietary DHA supplementation in an APP\/PS1 transgenic rat model of AD reduces behavioral and A\u03b2 pathology and modulates A\u03b2 oligomerization"],"prefix":"10.1016","volume":"82","author":[{"given":"Edmond","family":"Teng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Bilousova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Weiland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thaidan","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fusheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles G.","family":"Glabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Takacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis R.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally A.","family":"Frautschy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2015.09.002_bb0005","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nsmb.1799","article-title":"Structural conversion of neurotoxic amyloid-beta(1\u201342) oligomers to fibrils","volume":"17","author":"Ahmed","year":"2010","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.nbd.2015.09.002_bb0010","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.neuroscience.2007.08.018","article-title":"A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice","volume":"149","author":"Arendash","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2015.09.002_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017397","article-title":"DHA improves cognition and prevents dysfunction of entorhinal cortex neurons in 3xTg-AD mice","volume":"6","author":"Arsenault","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2015.09.002_bb0020","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.neuropharm.2008.02.003","article-title":"Docosahexaenoic and eicosapentaenoic acids increase neuronal death in response to HuPrP82-146 and Abeta 1\u201342","volume":"54","author":"Bate","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2015.09.002_bb0025","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrn3820","article-title":"Polyunsaturated fatty acids and their metabolites in brain function and disease","volume":"15","author":"Bazinet","year":"2014","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.nbd.2015.09.002_bb0030","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nn.3028","article-title":"The toxic Abeta oligomer and Alzheimer's disease: an emperor in need of clothes","volume":"15","author":"Benilova","year":"2012","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.nbd.2015.09.002_bb0035","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.nbd.2014.11.006","article-title":"Parallel age-associated changes in brain and plasma neuronal pentraxin receptor levels in a transgenic APP\/PS1 rat model of Alzheimer's disease","volume":"74","author":"Bilousova","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.nbd.2015.09.002_bb0040","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/y59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1954","journal-title":"Can J Biochem Physiol"},{"key":"10.1016\/j.nbd.2015.09.002_bb0045","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3233\/JAD-2012-112039","article-title":"A specific multi-nutrient diet reduces Alzheimer-like pathology in young adult AbetaPPswe\/PS1dE9 mice","volume":"33","author":"Broersen","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.nbd.2015.09.002_bb0050","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1460-9568.2005.04253.x","article-title":"Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease","volume":"22","author":"Calon","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.nbd.2015.09.002_bb0055","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.neuron.2004.08.013","article-title":"Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model","volume":"43","author":"Calon","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2015.09.002_bb0060","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.pnpbp.2008.05.015","article-title":"The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study","volume":"32","author":"Chiu","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.nbd.2015.09.002_bb0065","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3945\/jn.109.113910","article-title":"DHA may prevent age-related dementia","volume":"140","author":"Cole","year":"2010","journal-title":"J Nutr"},{"key":"10.1016\/j.nbd.2015.09.002_bb0070","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.plefa.2009.05.015","article-title":"Omega-3 fatty acids and dementia","volume":"81","author":"Cole","year":"2009","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.nbd.2015.09.002_bb0075","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1750-1326-8-37","article-title":"Modeling Alzheimer's disease in transgenic rats","volume":"8","author":"Do Carmo","year":"2013","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.nbd.2015.09.002_bb0080","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000225376","article-title":"Oligomerization partially explains the lowering of Abeta42 in Alzheimer's disease cerebrospinal fluid","volume":"6","author":"Englund","year":"2009","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.nbd.2015.09.002_bb0085","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.neurobiolaging.2007.10.006","article-title":"A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition","volume":"30","author":"Flood","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.nbd.2015.09.002_bb0090","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1471-4159.2005.03541.x","article-title":"Docosahexaenoic acid prevents neuronal apoptosis induced by soluble amyloid-beta oligomers","volume":"96","author":"Florent","year":"2006","journal-title":"J Neurochem"},{"key":"10.1016\/j.nbd.2015.09.002_bb0095","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1001\/archneur.63.10.1402","article-title":"Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial","volume":"63","author":"Freund-Levi","year":"2006","journal-title":"Arch Neurol"},{"key":"10.1016\/j.nbd.2015.09.002_bb0100","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1523\/JNEUROSCI.0055-07.2007","article-title":"Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels","volume":"27","author":"Green","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.nbd.2015.09.002_bb0105","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neuron.2013.04.014","article-title":"Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta","volume":"78","author":"Griciuc","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2015.09.002_bb0110","doi-asserted-by":"crossref","first-page":"14028","DOI":"10.1074\/jbc.M110.182329","article-title":"Docosahexaenoic acid reduces amyloid beta production via multiple pleiotropic mechanisms","volume":"286","author":"Grimm","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nbd.2015.09.002_bb0115","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jnutbio.2009.11.005","article-title":"Docosahexaenoic acid withstands the Abeta(25\u201335)-induced neurotoxicity in SH-SY5Y cells","volume":"22","author":"Hashimoto","year":"2011","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.nbd.2015.09.002_bb0120","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bbalip.2009.01.012","article-title":"Effects of docosahexaenoic acid on in vitro amyloid beta peptide 25\u201335 fibrillation","volume":"1791","author":"Hashimoto","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nbd.2015.09.002_bb0125","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1471-4159.2008.05731.x","article-title":"Docosahexaenoic acid disrupts in vitro amyloid beta(1\u201340) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer's disease model rats","volume":"107","author":"Hashimoto","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.nbd.2015.09.002_bb0130","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3233\/JAD-130131","article-title":"Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-beta42 by human microglia and decrease inflammatory markers","volume":"35","author":"Hjorth","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.nbd.2015.09.002_bb0135","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/00005176-200011000-00016","article-title":"Impact of early dietary intake and blood lipid composition of long-chain polyunsaturated fatty acids on later visual development","volume":"31","author":"Hoffman","year":"2000","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.nbd.2015.09.002_bb0140","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.neuron.2014.02.027","article-title":"Soluble A\u03b2 oligomers are rapidly sequestered from brain ISF and bind GM1 ganglioside on cellular membranes","volume":"82","author":"Hong","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2015.09.002_bb0145","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1471-4159.2009.06336.x","article-title":"Mechanism of docosahexaenoic acid-induced inhibition of in vitro Abeta1-42 fibrillation and Abeta1-42-induced toxicity in SH-S5Y5 cells","volume":"111","author":"Hossain","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.nbd.2015.09.002_bb0150","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1742-4658.2007.05647.x","article-title":"Docosahexaenoic acid stabilizes soluble amyloid-beta protofibrils and sustains amyloid-beta-induced neurotoxicity in vitro","volume":"274","author":"Johansson","year":"2007","journal-title":"FEBS J"},{"key":"10.1016\/j.nbd.2015.09.002_bb0155","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/cdd.2013.180","article-title":"Microglia convert aggregated amyloid-beta into neurotoxic forms through the shedding of microvesicles","volume":"21","author":"Joshi","year":"2014","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.nbd.2015.09.002_bb0160","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1523\/JNEUROSCI.21-02-00372.2001","article-title":"Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease","volume":"21","author":"Kawarabayashi","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.nbd.2015.09.002_bb0165","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-1326-2-18","article-title":"Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers","volume":"2","author":"Kayed","year":"2007","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.nbd.2015.09.002_bb0170","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.nbd.2015.09.002_bb0175","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1212\/WNL.0000000000000438","article-title":"Beta-amyloidosis and neurodegeneration in Alzheimer disease: who's on first?","volume":"82","author":"Knopman","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2015.09.002_bb0180","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jnutbio.2013.09.015","article-title":"Special lipid-based diets alleviate cognitive deficits in the APPswe\/PS1dE9 transgenic mouse model of Alzheimer's disease independent of brain amyloid deposition","volume":"25","author":"Koivisto","year":"2014","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.nbd.2015.09.002_bb0185","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neures.2006.06.010","article-title":"Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction","volume":"56","author":"Kotani","year":"2006","journal-title":"Neurosci Res"},{"key":"10.1016\/j.nbd.2015.09.002_bb0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060921","article-title":"Functional impairment of microglia coincides with beta-amyloid deposition in mice with Alzheimer-like pathology","volume":"8","author":"Krabbe","year":"2013","journal-title":"PLoS One"},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2015.09.002_bb0195","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1471-4159.2011.07478.x","article-title":"Soluble Abeta oligomer production and toxicity","volume":"120","author":"Larson","year":"2012","journal-title":"J Neurochem"},{"key":"10.1016\/j.nbd.2015.09.002_bb0200","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00213-012-2848-0","article-title":"Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial","volume":"225","author":"Lee","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.nbd.2015.09.002_bb0205","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ajpath.2014.09.016","article-title":"Prostaglandin E2 receptor subtype 2 regulation of scavenger receptor CD36 modulates microglial Abeta42 phagocytosis","volume":"185","author":"Li","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.nbd.2015.09.002_bb0210","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1523\/JNEUROSCI.4225-04.2005","article-title":"A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model","volume":"25","author":"Lim","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.nbd.2015.09.002_bb0215","doi-asserted-by":"crossref","first-page":"8370","DOI":"10.1523\/JNEUROSCI.21-21-08370.2001","article-title":"The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse","volume":"21","author":"Lim","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.nbd.2015.09.002_bb0220","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.nbd.2004.08.005","article-title":"Longitudinal observation on CSF Abeta42 levels in young to middle-aged amyloid precursor protein\/presenilin-1 doubly transgenic mice","volume":"17","author":"Liu","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.nbd.2015.09.002_bb0225","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.nbd.2008.03.005","article-title":"A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment","volume":"31","author":"Liu","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.nbd.2015.09.002_bb0230","doi-asserted-by":"crossref","first-page":"194re2","DOI":"10.1126\/scitranslmed.3006446","article-title":"Changes in amyloid-beta and Tau in the cerebrospinal fluid of transgenic mice overexpressing amyloid precursor protein","volume":"5","author":"Maia","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.nbd.2015.09.002_bb0235","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/297681a0","article-title":"Place navigation impaired in rats with hippocampal lesions","volume":"297","author":"Morris","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2015.09.002_bb0240","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nature11060","article-title":"Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-beta","volume":"485","author":"Nussbaum","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2015.09.002_bb0245","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.nbd.2006.04.013","article-title":"Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP\/PS1 transgenic mice","volume":"23","author":"Oksman","year":"2006","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.nbd.2015.09.002_bb0250","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1750-1326-6-45","article-title":"Microglial phagocytosis induced by fibrillar beta-amyloid is attenuated by oligomeric beta-amyloid: implications for Alzheimer's disease","volume":"6","author":"Pan","year":"2011","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.nbd.2015.09.002_bb0255","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1002\/jnr.22266","article-title":"DHA diet reduces AD pathology in young APPswe\/PS1 Delta E9 transgenic mice: possible gender effects","volume":"88","author":"Perez","year":"2010","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.nbd.2015.09.002_bb0260","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1093\/brain\/awt171","article-title":"Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology","volume":"136","author":"Perez-Nievas","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2015.09.002_bb0265","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1023\/A:1014227231130","article-title":"Quantification of free fatty acids in human cerebrospinal fluid","volume":"26","author":"Pilitsis","year":"2001","journal-title":"Neurochem Res"},{"key":"10.1016\/j.nbd.2015.09.002_bb0270","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nbd.2015.09.002_bb0275","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2010.1510","article-title":"Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial","volume":"304","author":"Quinn","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.nbd.2015.09.002_bb0280","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/jnc.12305","article-title":"Systemic vaccination with anti-oligomeric monoclonal antibodies improves cognitive function by reducing Abeta deposition and tau pathology in 3xTg-AD mice","volume":"126","author":"Rasool","year":"2013","journal-title":"J Neurochem"},{"key":"10.1016\/j.nbd.2015.09.002_bb0285","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1179\/1476830511Y.0000000032","article-title":"Effects of a diet integration with an oily emulsion of DHA-phospholipids containing melatonin and tryptophan in elderly patients suffering from mild cognitive impairment","volume":"15","author":"Rondanelli","year":"2012","journal-title":"Nutr Neurosci"},{"key":"10.1016\/j.nbd.2015.09.002_bb0290","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-1-61779-551-0_3","article-title":"Preparation of stable amyloid beta-protein oligomers of defined assembly order","volume":"849","author":"Rosensweig","year":"2012","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.nbd.2015.09.002_bb0295","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.nbd.2015.09.002_bb0300","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1017\/S0007114511004788","article-title":"Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial","volume":"107","author":"Sinn","year":"2012","journal-title":"Br J Nutr"},{"key":"10.1016\/j.nbd.2015.09.002_bb0305","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.nbd.2011.05.003","article-title":"[F-18]FDDNP microPET imaging correlates with brain Abeta burden in a transgenic rat model of Alzheimer disease: effects of aging, in vivo blockade, and anti-Abeta antibody treatment","volume":"43","author":"Teng","year":"2011","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.nbd.2015.09.002_bb0310","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.nbd.2009.05.024","article-title":"Soluble fibrillar oligomer levels are elevated in Alzheimer's disease brain and correlate with cognitive dysfunction","volume":"35","author":"Tomic","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.nbd.2015.09.002_bb0315","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1159\/000310330","article-title":"Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial","volume":"29","author":"Vakhapova","year":"2010","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.nbd.2015.09.002_bb0320","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0021-9150(02)00046-1","article-title":"Unsaturated fatty acids and their oxidation products stimulate CD36 gene expression in human macrophages","volume":"164","author":"Vallve","year":"2002","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.nbd.2015.09.002_bb0325","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3233\/JAD-120163","article-title":"Docosahexaenoic acid reduces amyloid-beta induced toxicity in cells of the neurovascular unit","volume":"36","author":"Veszelka","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.nbd.2015.09.002_bb0330","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jnutbio.2009.01.012","article-title":"Docosahexaenoic acid supplementation of primary rat hippocampal neurons attenuates the neurotoxicity induced by aggregated amyloid beta protein(42) and up-regulates cytoskeletal protein expression","volume":"21","author":"Wang","year":"2010","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.nbd.2015.09.002_bb0335","doi-asserted-by":"crossref","first-page":"17321","DOI":"10.1523\/JNEUROSCI.1569-12.2012","article-title":"PPARgamma\/RXRalpha-induced and CD36-mediated microglial amyloid-beta phagocytosis results in cognitive improvement in amyloid precursor protein\/presenilin 1 mice","volume":"32","author":"Yamanaka","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.nbd.2015.09.002_bb0340","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1074\/jbc.M404751200","article-title":"Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo","volume":"280","author":"Yang","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nbd.2015.09.002_bb0345","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1097\/00001756-199410270-00032","article-title":"Monoclonal antibody to the C-terminus of beta-amyloid","volume":"5","author":"Yang","year":"1994","journal-title":"Neuroreport"},{"key":"10.1016\/j.nbd.2015.09.002_bb0350","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jalz.2010.01.013","article-title":"Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline","volume":"6","author":"Yurko-Mauro","year":"2010","journal-title":"Alzheimers Dement"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115300486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996115300486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T03:01:14Z","timestamp":1718074874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996115300486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":70,"alternative-id":["S0969996115300486"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2015.09.002","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dietary DHA supplementation in an APP\/PS1 transgenic rat model of AD reduces behavioral and A\u03b2 pathology and modulates A\u03b2 oligomerization","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2015.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}